CHINA China's CanSino to offer tens of millions of COVID-19 vaccines to COVAX

CHINA

China's CanSino to offer tens of millions of COVID-19 vaccines to COVAX

Xinhua

19:00, March 27, 2021

An employee checks a machine inside a CanSino vaccine manufacturing plant based in Tianjin, China. (Photo: CFP)

BEIJING, March 27 (Xinhua) -- China's CanSino Biologics Inc has proposed providing "tens of million of doses" of its single-dose COVID-19 vaccine to global vaccine sharing scheme COVAX, Reuters quoted a senior executive of the company as saying.

Pierre Morgon, senior vice president at CanSino, told the media outlet in an interview that the firm made the proposal in December last year to supply vaccines between late 2021 and the end of 2022.

"We are happy to go beyond 2022 if there was still an expectation to do so," Morgon was quoted in the report on Thursday.

The offering to COVAX, which is backed by the World Health Organization, is the lowest price that CanSino uses in markets outside China, where richer countries are subject to prices about three times higher, the report added.

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue